【レポートの概要（一部）】
1 Introduction (Page No. – 16)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. – 19)
2.1 Research Data
2.2 Secondary Data
2.2.1 Key Data From Secondary Sources
2.3 Primary Data
2.3.1 Key Data From Primary Sources
2.4 Market Size Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Data Triangulation
2.6 Assumptions for the Study
3 Executive Summary (Page No. – 27)
4 Premium Insights (Page No. – 32)
4.1 Drug Discovery Services Market Overview
4.2 European Market Share, By Therapeutic Area and Country
4.3 Global Market, By Type
4.4 Geographical Snapshot of the Global Market
5 Market Overview (Page No. – 36)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing R&D Expenditure
5.2.1.2 Increasing Demand for Outsourcing Analytical Testing and Clinical Trial Services
5.2.1.3 Initiatives for Research on Rare Diseases
5.2.1.4 Focus on Drug Discovery
5.2.2 Restraints
5.2.2.1 High Cost of Drug Discovery and Development
5.2.2.2 Stringent Regulations Governing Drug Discovery, and Animal Usage
5.2.3 Opportunities
5.2.3.1 Introduction of Advanced Technologies
5.2.3.2 Patent Expiries to Boost the Demand for Drug Discovery
5.2.4 Burning Issues
5.2.4.1 Need for Harmonization of Regulations, Ip Rights
6 Drug Discovery Services Market, By Process (Page No. – 44)
6.1 Introduction
6.2 Target Selection
6.3 Target Validation
6.4 Hit-To-Lead Identification
6.5 Lead Optimization
6.6 Candidate Validation
7 Drug Discovery Services Market, By Type (Page No. – 51)
7.1 Introduction
7.2 Medicinal Chemistry
7.3 Biology Services
7.4 Drug Metabolism and Pharmacokinetics (DMPK)
8 Drug Discovery Services Market, By Drug Type (Page No. – 56)
8.1 Introduction
8.2 Small Molecules
8.3 Biologics
9 Drug Discovery Services Market, By Therapeutic Area (Page No. – 60)
9.1 Introduction
9.2 Oncology
9.3 Neurology
9.4 Cardiovascular Diseases
9.5 Respiratory Diseases
9.6 Diabetes
9.7 Other Therapeutic Areas
10 Drug Discovery Services Market, By Region (Page No. – 69)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Rest of Europe (RoE)
10.4 Asia Pacific (APAC)
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Rest of Asia Pacific (RoAPAC)
10.5 Rest of the World (RoW)
11 Competitive Landscape (Page No. – 115)
11.1 Market Share Analysis
12 Company Profiles (Page No. – 116)
(Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments)*
12.1 Thermo Fisher Scientific
12.2 Merck
12.3 GE Healthcare
12.4 Albany Molecular Research, Inc. (AMRI)
12.5 Charles River Laboratories International
12.6 Evotec
12.7 Pharmaceutical Product Development, LLC. (Ppd)
12.8 Jubilant Biosys
12.9 Covance
12.10 Genscript Biotech Corporation
12.11 Aurigene Discovery Technologies
12.12 Wuxi Apptec
12.13 Syngene
*Details on Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments Might Not Be Captured in Case of Unlisted Companies.
13 Appendix (Page No. – 159)
13.1 Industry Insights
13.2 Discussion Guide
13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.4 Introducing RT: Real-Time Market Intelligence
13.5 Available Customizations
13.6 Related Reports
13.7 Author Details
List of Tables (92 Tables)
Table 1 Total Global Pharmaceutical R&D Spending, 2012 to 2022 (USD Billion)
Table 2 R&D Spending, Phrma Member-Companies (USD Billion)
Table 3 Activities Outsourced in the Pharmaceutical Industry (2014 vs 2015)
Table 4 Research Projects Funded By Irdirc Bodies
Table 5 Average Cost of Drugs Approved By Year
Table 6 Drug Discovery Services Market, By Process, 2015–2022 (USD Million)
Table 7 Target Selection Market, By Region, 2015–2022 (USD Million)
Table 8 Target Validation Market, By Region, 2015–2022 (USD Million)
Table 9 Hit-To-Lead Identification Process Market, By Region, 2015–2022 (USD Million)
Table 10 Lead Optimization Market, By Region, 2015–2022 (USD Million)
Table 11 Candidate Validation Market, By Region, 2015–2022 (USD Million)
Table 12 Drug Discovery Services Market, By Type, 2015–2022 (USD Million)
Table 13 Medicinal Chemistry Services Market, By Region, 2015–2022 (USD Million)
Table 14 Biology Services Market, By Region, 2015–2022 (USD Million)
Table 15 Drug Metabolism and Pharmacokinetics Services Market, By Region, 2015–2022 (USD Million)
Table 16 Drug Discovery Services Market, By Drug Type, 2015–2022 (USD Million)
Table 17 Small Molecules Market, By Region, 2015–2022 (USD Million)
Table 18 Biologics Market, By Region, 2015–2022 (USD Million)
Table 19 Global Number of Clinical Trials in Different Therapeutic Areas, 2016
Table 20 Global Drug Discovery Services Market, By Therapeutic Area, 2015–2022 (USD Million)
Table 21 Market for Oncology, By Region, 2015–2022 (USD Million)
Table 22 Market for Neurology, By Region, 2015–2022 (USD Million)
Table 23 Market for Cardiovascular Diseases, By Region, 2015–2022 (USD Million)
Table 24 Market for Respiratory Diseases, By Region, 2015–2022 (USD Million)
Table 25 Drug Discovery Services Market for Diabetes, By Region, 2015–2022 (USD Million)
Table 26 Market for Other Therapeutic Areas, By Region, 2015–2022 (USD Million)
Table 27 Market, By Region, 2015–2022 (USD Million)
Table 28 North America: Drug Discovery Services Market, By Country, 2015–2022 (USD Million)
Table 29 North America: Market, By Process, 2015–2022 (USD Million)
Table 30 North America: Market, By Type, 2015–2022 (USD Million)
Table 31 North America: Market, By Drug Type, 2015–2022 (USD Million)
Table 32 North America: Market, By Therapeutic Area, 2015–2022 (USD Million)
Table 33 US: Drug Discovery Services Market, By Process, 2015–2022 (USD Million)
Table 34 US: Market, By Type, 2015–2022 (USD Million)
Table 35 US: Market, By Drug Type, 2015–2022 (USD Million)
Table 36 US: Market, By Therapeutic Area, 2015–2022 (USD Million)
Table 37 Canada: Drug Discovery Services Market, By Process, 2015–2022 (USD Million)
Table 38 Canada: Market, By Type, 2015–2022 (USD Million)
Table 39 Canada: Market, By Drug Type, 2015–2022 (USD Million)
Table 40 Canada: Market, By Therapeutic Area, 2015–2022 (USD Million)
Table 41 Europe: Pharmaceutical R&D Expenditure, By Country, 2012 & 2014
Table 42 Europe: Market, By Country/Region, 2015 –2022 (USD Million)
Table 43 Europe: Drug Discovery Services Market, By Process, 2015–2022 (USD Million)
Table 44 Europe: Market, By Type, 2015–2022 (USD Million)
Table 45 Europe: Market, By Drug Type, 2015–2022 (USD Million)
Table 46 Europe: Market, By Therapeutic Area, 2015–2022 (USD Million)
Table 47 Pharmaceutical R&D Investments in Germany (2010–2014)
Table 48 Germany: Drug Discovery Services Market, By Process, 2015–2022 (USD Million)
Table 49 Germany: Market, By Type, 2015–2022 (USD Million)
Table 50 Germany: Market, By Drug Type, 2015–2022 (USD Million)
Table 51 Germany: Market, By Therapeutic Area, 2015–2022 (USD Million)
Table 52 UK: Drug Discovery Services Market, By Process, 2015–2022 (USD Million)
Table 53 UK: Market, By Type, 2015–2022 (USD Million)
Table 54 UK: Market, By Drug Type, 2015–2022 (USD Million)
Table 55 UK: Market, By Therapeutic Area, 2015–2022 (USD Million)
Table 56 France: Drug Discovery Services Market, By Process, 2015–2022 (USD Million)
Table 57 France: Market, By Type, 2015–2022 (USD Million)
Table 58 France: Market, By Drug Type, 2015–2022 (USD Million)
Table 59 France: Market, By Therapeutic Area, 2015–2022 (USD Million)
Table 60 Pharmaceutical R&D Investments in Italy, 2009–2014
Table 61 Pharmaceutical R&D Expenditure in Belgium, 2010–2014
Table 62 Pharmaceutical Production and R&D Expenditure in Denmark, 2012–2014
Table 63 RoE: Drug Discovery Services Market, By Process, 2015–2022 (USD Million)
Table 64 RoE: Market, By Type, 2015–2022 (USD Million)
Table 65 RoE: Market, By Drug Type, 2015–2022 (USD Million)
Table 66 RoE: Market, By Therapeutic Area, 2015–2022 (USD Million)
Table 67 Total Number of Clinical Trials in APAC, By Therapeutic Area, 2016
Table 68 APAC: Drug Discovery Services Market, By Country/Region, 2015–2022 (USD Million)
Table 69 APAC: Market, By Process, 2015–2022 (USD Million)
Table 70 APAC: Market, By Type, 2015–2022 (USD Million)
Table 71 APAC: Market, By Drug Type, 2015–2022 (USD Million)
Table 72 APAC: Market, By Therapeutic Area, 2015–2022 (USD Million)
Table 73 China: Drug Discovery Services Market, By Process, 2015–2022 (USD Million)
Table 74 China: Market, By Type, 2015–2022 (USD Million)
Table 75 China: Market, By Drug Type, 2015–2022 (USD Million)
Table 76 China: Market, By Therapeutic Area, 2015–2022 (USD Million)
Table 77 Japan: Drug Discovery Services Market, By Process, 2015–2022 (USD Million)
Table 78 Japan: Market, By Type, 2015–2022 (USD Million)
Table 79 Japan: Market, By Drug Type, 2015–2022 (USD Million)
Table 80 Japan: Market, By Therapeutic Area, 2015–2022 (USD Million)
Table 81 India: Drug Discovery Services Market, By Process, 2015–2022 (USD Million)
Table 82 India: Market, By Type, 2015–2022 (USD Million)
Table 83 India: Market, By Drug Type, 2015–2022 (USD Million)
Table 84 India: Market, By Therapeutic Area, 2015–2022 (USD Million)
Table 85 RoAPAC: Drug Discovery Services Market, By Process, 2015–2022 (USD Million)
Table 86 RoAPAC: Market, By Type, 2015–2022 (USD Million)
Table 87 RoAPAC: Market, By Drug Type, 2015–2022 (USD Million)
Table 88 RoAPAC: Market, By Therapeutic Area, 2015–2022 (USD Million)
Table 89 RoW: Drug Discovery Services Market, By Process, 2015–2022 (USD Million)
Table 90 RoW: Market, By Type, 2015–2022 (USD Million)
Table 91 RoW: Market, By Drug Type, 2015–2022 (USD Million)
Table 92 RoW: Market, By Therapeutic Area, 2015–2022 (USD Million)
List of Figures (39 Figures)
Figure 1 Global Drug Discovery Services Market
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Data Triangulation Methodology
Figure 5 Drug Discovery Services Market, By Process, 2017 vs 2022 (USD Billion)
Figure 6 Global Market, By Type, 2017 vs 2022 (USD Billion)
Figure 7 Global Market, By Drug Type, 2017 vs 2022 (USD Billion)
Figure 8 Global Market, By Therapeutic Area, 2017 vs 2022 (USD Billion)
Figure 9 Global Market, By Region, 2017 vs 2022 (USD Billion)
Figure 10 Increasing Demand for Outsourcing of Analytical Testing and Clinical Trial Services to Drive Market Growth
Figure 11 Oncology Segment to Command the Largest Market Share of European Drug Discovery Services Market in 2017
Figure 12 Medicinal Chemistry to Register the Highest CAGR During the Forecast Period (2017-2022)
Figure 13 Asia Pacific to Register the Highest CAGR Between 2017 & 2022
Figure 14 Drug Discovery Services Market: Drivers, Restraints, and Opportunities
Figure 15 Number of Registered Studies (2000-2017)
Figure 16 Hit-To-Lead Identification to Hold Largest Market Share in 2017
Figure 17 Medicinal Chemistry Segment to Account for the Largest Share of the Drug Discovery Services Market
Figure 18 Small Molecules—The Largest Segment in the Global Market, By Drug Types
Figure 19 Oncology Segment to Hold the Largest Share in Global Market in 2017
Figure 20 Total Number of Clinical Trials for Oncology (2016)
Figure 21 Geographic Snapshot (2016): APAC Markets are Emerging as New Growth Hotspots
Figure 22 North America: Drug Discovery Services Market Snapshot
Figure 23 Pharmaceutical R&D Expenditure in the US (1990-2014)
Figure 24 Total Canadian Pharmaceutical Trade (2004–2016) (USD Billion)
Figure 25 Yearly Employment in Manufacturing Portion of Pharmaceutical Sector (2005–2016)
Figure 26 Pharmaceutical R&D Expenditure in Europe (2010–2014)
Figure 27 Europe: Market Snapshot
Figure 28 APAC: Market Snapshot
Figure 29 Global Market: Market Share (2016)
Figure 30 Thermo Fisher Scientific: Company Snapshot (2016)
Figure 31 Merck: Company Snapshot (2016)
Figure 32 GE Healthcare: Company Snapshot (2016)
Figure 33 Albany Molecular Research, Inc.: Company Snapshot (2016)
Figure 34 Charles River Laboratories International: Company Snapshot (2016)
Figure 35 Evotec: Company Snapshot (2016)
Figure 36 Jubilant Biosys: Company Snapshot (2016)
Figure 37 Labcorp: Company Snapshot (2016)
Figure 38 Genscript Biotech Corporation: Company Snapshot (2016)
Figure 39 Syngene: Company Snapshot (2016)
【レポート販売概要】
■ タイトル：創薬サービスの世界市場予測（～2022年）：医薬品化学、生物学サービス、DMPK■ 英文：Drug Discovery Services Market by Process (Target Selection, Hit-to-Lead Identification, Lead Optimization), Type (Medicinal Chemistry, Biology Services, DMPK), Drug Type (Small Molecules, Biologics), Therapeutic Areas (Oncology, Neurology) - Forecast to 2022
■ 発行日：2017年10月27日
■ 調査会社：MarketsandMarkets
■ 商品コード：PH-5682
■ 調査対象地域：グローバル
- 産業用変速ベルトの世界市場2017-2021ABSTRACTAbout Industrial Variable Speed Belts Industrial variable speed belts are used in applications wherein changes in speed during operation are common. They are a part of the V-belt family. However, they differ in shape considerably as compared with the standard V-belt, which has a distinctly broader width and a narrower thickness. The global industrial variable speed belts market focuses on …
- Laboratoires Urgo S.A.：市場シェア分析Laboratoires Urgo S.A. Market Share Analysis Summary GlobalData’s new report, “Laboratoires Urgo S.A. Market Share Analysis” provides in-depth information on Laboratoires Urgo S.A.’s market position in the different medical equipment markets it operates in. The report provides Laboratoires Urgo S.A. market share information in four key market categories – Advanced Wound Management, Compression The …
- 空港自動保安検査の世界市場2017-2021About Automated Airport Security Screening Airport screening systems are being used at the airport security checkpoints since decades. Previously, most of the airport screening process relied on handheld metal detectors or walk-through metal detectors and X-ray systems. However, with the increasing security threats and the inability of the metal detectors to detect non-metallic objects and explosi …
- ナノセルロースの世界市場：セルロース・ナノクリスタル、セルロース・ナノフィブリル、セルロース・ナノ複合材料The nano cellulose market is estimated around $ 250 million in 2014, with the high share held by North America and Europe together. The global nano cellulose market by value is projected to grow at a CAGR of approximately 19% from 2014 to 2019. The high growth is forecasted to be in the North America and Europe due to rising advancements in the end industries such as paper and paper board, composi …
- 世界の血液型検査/分類、感染症スクリーニング検査（医療機器）市場This unique report from Venture Planning Group provides sales and market share estimates for major suppliers of blood typing, grouping and infectious disease screening products by test and country. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, co …
- 超音波試験の世界市場：TOFD法、フェーズドアレイ、浸せき試験、ガイド波試験The ultrasonic testing (UT) market is expected to reach USD 3.93 Billion by 2022, at a CAGR of 8.3% between 2016 and 2022. Development of portable phased array ultrasonic testing equipment, need for reliable non-destructive testing technique for fiberglass and carbon fiber composites in manufacturing, growth in ultrasonic testing services market, and government regulations are the factors driving …
- 心臓血管トレーニング器具の世界市場2016-2020About Cardiovascular Training Equipment Cardiovascular training equipment consists of the following types of machines: Treadmills - A treadmill is one of the most popular workout machines. It simulates road running and helps cross-train for any sports or activities that involve walking or running. Ellipticals - An elliptical is a combination of walking, running, and cycling. It provides an arms an …
- 世界のマイクロタービン（Microturbine）市場動向（2014～2018）TechNavio's analysts forecast the Global Microturbine market to grow at a CAGR of 17.1 percent over the period 2013-2018. One of the key factors contributing to this market growth is the rising global energy demand. The Global Microturbine market has also been witnessing the opportunity to sell excess power to main grids. However, the difficulty in interconnection with power grids could pose a cha …
- フッ素系界面活性剤の世界市場予測（～2021年）“Fluorosurfactants market to grow at a CAGR of 9.8% during the forecast period”The fluorosurfactants market size is projected to reach USD 667.4 million by 2021, at a CAGR of 9.8% from 2016 to 2021. Fluorosurfactants are recognized as synthetic organo-fluorine compounds with multiple fluorine atoms. Fluorosurfactants reduce the surface tension of organic or aqueous solutions and act as wetting, le …
- ベビー用安全用品の世界市場：ベビーカー、ベビーモニタ、ベビーベッド、チャイルドシートAbout Baby Safety Products Baby safety products include baby strollers and prams, baby monitors, baby cribs, and baby car seats. Baby strollers and prams and baby car seats are of different types depending upon the weight and age of a baby. With latest advances, the baby gear technology is making it easier for parents to carry infants and babies comfortably and conveniently. Baby monitor is a devi …
- 宅配便・急行便・小包サービスの世界市場About CEP CEPs are used for the delivery of parcels and documents to various types of customers such as business customers, retail customers, and government agencies. The documents and parcels delivered by the CEP vendors are non-palletized items and weigh less than 110 pounds. Express delivery is a time-bound delivery, where the shipment is delivered within a day or two and also as per the requir …
- 2014年戦略提言：スペインの腸疾患診断検査市場About This ReportThis new 322-page report from Venture Planning Group presents detailed analysis of the Spanish Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. The report provides test volume and sales projections for Hospitals and Commercial/Priv …
- コートジボワールの個人障害保険・健康保険市場"Trends and Opportunities in Cote d’Ivoire Personal Accident and Health Insurance Industry to 2018: Market Profile" is the result of extensive research into the personal accident and health insurance segment in Cote d’Ivoire. It provides insights into the market trends, market size, growth prospects and market efficiency in the Ivoirian personal accident and health insurance market.
- 一回用バイオプロセスシステムの世界市場2015-2019About Single-use Bioprocessing System Single-use bioprocessing technology is a rapidly evolving technology that focuses on developing disposable bioprocessing equipment and accessories for manufacturing biopharmaceutical products. Bioprocess is the process that utilize living cells or their components such as enzymes, bacteria, and others to obtain preferred products. The central idea behind the u …
- アクセス制御の世界市場予測（～2024年）“Access control market to grow at 8.24% CAGR from 2018 to 2024” The access control market is expected to grow from USD 7.5 billion in 2018 to USD 12.1 billion by 2024, at a CAGR of 8.24% from 2018 to 2024. The growth of this market is mainly driven by high adoption of access control solutions owing to increasing crime rates globally; technological advancements and deployment of wireless technology …
